Epic Bio to Present at the Upcoming Annual European Society of Gene and Cell Therapy
October 19, 2023 06:00 ET
|
Epic Bio
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
Epic Bio Announces the Appointment of Weston Miller, M.D., as Chief Medical Officer
October 17, 2023 06:00 ET
|
Epic Bio
SOUTH SAN FRANCISCO, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
Epic Bio to Present at the Upcoming BMO Life Sciences Private Company Showcase
October 05, 2023 09:00 ET
|
Epic Bio
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
Global Epigenomics Market Research Report 2023-2031 Featuring Epigenomics AG, Illumina, Merck, Zymo Research, & Agilent Technologies
October 03, 2023 07:03 ET
|
Research and Markets
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Epigenomics Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global epigenomics market...
Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
September 28, 2023 09:00 ET
|
Epic Bio
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
September 19, 2023 09:00 ET
|
Epic Bio
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today...
Epic Bio Reports Discovery of Exceptionally Durable Gene Activators and Creation of Machine Learning Algorithm to Design New Activators
September 14, 2023 12:00 ET
|
Epic Bio
- Vast high-throughput screening study used to train unique machine learning algorithm to design synthetic activators - - Rational engineering produced activators that induce the most...
Global Epigenetic Therapeutics Market to Reach $9.8 Billion by 2028 - Projected Revenue Shares for PRAP, Kinase, IDH, HDAC, DNMT, and KMT Inhibitors
June 23, 2023 05:08 ET
|
Research and Markets
Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Epigenetic Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global epigenetic therapeutics market was...
NGS-Based RNA-sequencing Markets: Sample Preparation, Platforms & Consumables, Services, Data Analysis, De Novo, Epigenetics, Small RNA - Global Forecast to 2027
May 26, 2023 07:23 ET
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "NGS-Based RNA-sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS,...
Metagenomic Global Market Report to 2027: New Approach to Diagnostics Drives Growth
May 01, 2023 04:18 ET
|
Research and Markets
Dublin, May 01, 2023 (GLOBE NEWSWIRE) -- The "Metagenomic Markets: Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2023...